SCHEMBL30003430

SCHEMBL30003430

Cc1ncc(C(C)Br)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3265716 0.78 LMNA (0.32)
SCHEMBL1923565 0.77
SCHEMBL25559736 0.75 CYP19A1 (0.31)
SCHEMBL996985 0.74 ADRB2 (0.37)
SCHEMBL441306 0.74 ADRB2 (0.37)
SCHEMBL996997 0.74 APLNR (0.38)
SCHEMBL22778736 0.74
SCHEMBL1000434 0.74 ADRB2 (0.37)
SCHEMBL9610894 0.73 LMNA (0.40)
Hydrochloric Acid SCHEMBL28480125 0.72 ADRB2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240287070-A1 FUSED HETEROCYCLIC DERIVATIVES JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. (CN) 2024-08-29 US disclosed
EP-4347590-A1 FUSED HETEROCYCLIC DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2024-04-10 EP disclosed
CN-117715909-A Condensed heterocyclic derivative 杨森科学爱尔兰无限公司 2024-03-15 CN disclosed
WO-2022253259-A1 FUSED HETEROCYCLIC DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2022-12-08 WO disclosed